StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Core SG&A expense YoY actual by Quarter

Core SG&A expense YoY actual (%) (%)

QuarterlyAnnual

AstraZeneca Core SG&A expense YoY actual: 7.0% in Q2 2026, up 5.0 pts from a year earlier.

Latest, Q2 2026
7.0%
Period ended Jun 30, 2026
Change on a year earlier
+5.0 pts
2.0% in Q2 2025
History
22 quarters
Since Q4 2020
Sources
22
Documents cited below

Where the Q2 2026 figure comes from

“|| SG&A expense | | (5,651) | | | 72 | | | 1,183 | | 346 | | (4,050) | 7 | 4”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Core Financial Measures.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore SG&A expense YoY actual (%) (%)Year on yearSource
Q2 2026Jun 30, 20267.0%+5.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202612.0%+11.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20254.0%-2.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20256.0%-2.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20252.0%-11.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20251.0%-11.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20246.0%-7.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20248.0%+2.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202413.0%+8.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202412.0%+8.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202313.0%+7.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20236.0%-4.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20235.0%–Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20234.0%-19.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20226.0%-13.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202210.0%-22.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Core SG&A expense YoY actual (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/core-sga-act-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.